European Commission 21 February 2017, Commission Decision of 21/02/2017 declaring a concentration to be compatible with the common market (Case No COMP/M.8237 - JOHNSON & JOHNSON / ABBOTT MEDICAL OPTICS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION Brussels,21.2.2017 C(2017) 1336 final To the notyfing party: Subject:Case M.8237 – Johnson & Johnson / Abbott Medical Optics Commission decision pursuant to Article 6(1)(b) of Council Regulation No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, (1)On 17 January 2017, the European Commission received notification of a proposed